[ad_1]
Brendan Kennedy, CEO of Tilray, told CNRA on Tuesday that pharmaceutical companies had to start thinking of partnering with cannabis companies as a "hedge" against the flourishing marijuana industry.
Source link
[ad_1]
Brendan Kennedy, CEO of Tilray, told CNRA on Tuesday that pharmaceutical companies had to start thinking of partnering with cannabis companies as a "hedge" against the flourishing marijuana industry.
Source link
Tags alcohol blanketquot invest quotBig